Coordinating Center for Genetics and Genomics of Alzheimer's Disease (CGAD)
阿尔茨海默病遗传学和基因组学协调中心 (CGAD)
基本信息
- 批准号:9472453
- 负责人:
- 金额:$ 25.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-08-01 至 2020-02-28
- 项目状态:已结题
- 来源:
- 关键词:AffectAfrican AmericanAlzheimer&aposs DiseaseAsiansBiometryCaribbean HispanicCollaborationsCost of IllnessDataData AnalysesData SetDatabasesDepositionDetectionDiseaseDisease ProgressionEnsureEthnic groupEuropeanFamilyFundingGene TargetingGenesGeneticGenetic ResearchGenetic studyGenomicsGenotypeGoalsGrantHereditary DiseaseKnowledgeMeta-AnalysisNational Institute on AgingNucleotidesPathway AnalysisPathway interactionsPhaseProcessProtocols documentationQuality ControlResearch PersonnelRiskSiteSourceTestingTherapeuticTimeVariantbasecase controlcostdata managementdatabase of Genotypes and Phenotypesdesignexomegene discoverygenetic variantinsertion/deletion mutationinsightphenotypic datapreventpublic health relevancetherapeutic targetwhole genome
项目摘要
DESCRIPTION (provided by applicant): The goal of Alzheimer's disease (AD) genetics research is to identify genetic variants that cause, influence risk, or protect against this disordr, and to identify the underlying genes affected by these variants. These genes are then potential therapeutic targets. The goal of the NIA Coordinating Center for Genetics and Genomics of Alzheimer's Disease (CGAD, this application) is to facilitate AD gene discovery by coordinating analysis of all AD-relevant data. As mandated by RFA AG16001, there are 3 cores and an Overall Component. The mandated cores are: 1) Administrative (Core A); 2) Data Management, Harmonization, and Information Transfer Core (Core B); and 3) Biostatistics and Data Analysis Core (Core C). As mandated by RFA AG16001, CGAD will assemble all data (Cores A and B) generated by the Alzheimer's Disease Sequence Project (ADSP) from both the Discovery Phase and the Replication Phase, and all data from non-ADSP sources (Core A) including that generated by grants funded under RFA AG16002. CGAD will; 1) create and support a collaborative network of all CGAD, ADSP, RFA AG16002, and other AD genetics investigators (Core A); 2) harmonize all genetic and phenotype data and fully annotate all variants (Core B); 2) design all harmonization and annotation protocols (Core C, implemented by Core B); 3) design analysis protocols for all data (Core C); 4) implement analyses plans (Core C, except for computationally intensive protocols that will be executed by Core B); 5) broadly distribute primary data, harmonized annotated analysis-ready files, and analyses results including depositing appropriate data into qualified access databases [National Institute on Aging Genetics of Alzheimer's Disease Storage site (NIAGADS) and database of Genotypes and Phenotypes (dbGaP)] (Core B). As mandated by RFA AG16001, all harmonization protocols and analyses plans will be refined in collaboration with all ADSP, RFA AG16002, and other AD genetics investigators. The Overall Component describes in detail the proposed activities and analyses to be executed by the cores. We will analyze Replication Phase data using single and gene-based analyses. Both single nucleotide variants (SNVs) and structural variants (SVs) will be analyzed. We will perform a combined analysis of Replication and Discovery Phase data. We will also perform an Extended Replication Phase using non- ADSP data. We will analyze data from all phases in a pathway network analysis, an interaction analysis, and a polygenic risk score. These gene-discovery activities will lead to potential targets for developing therapeutics.
描述(由申请人提供):阿尔茨海默病(AD)遗传学研究的目标是确定导致、影响风险或预防这种疾病的遗传变异,并确定受这些变异影响的潜在基因。这些基因是潜在的治疗靶点。NIA阿尔茨海默病遗传学和基因组学协调中心(CGAD,本申请)的目标是通过协调所有AD相关数据的分析来促进AD基因的发现。根据RFA AG 16001的规定,有3个核心和一个整体组件。规定的核心是:1)行政(核心A); 2)数据管理、协调和信息传输核心(核心B);和3)生物统计和数据分析核心(核心C)。根据RFA AG 16001的要求,CGAD将收集阿尔茨海默病序列项目(ADSP)在发现阶段和复制阶段生成的所有数据(核心A和B),以及来自非ADSP来源的所有数据(核心A),包括RFA AG 16002资助的赠款生成的数据。CGAD将; 1)创建并支持所有CGAD、ADSP、RFA AG 16002和其他AD遗传学研究者的协作网络(核心A); 2)协调所有遗传和表型数据并完整注释所有变体(核心B); 2)设计所有协调和注释方案(核心C,由核心B实施); 3)为所有数据设计分析方案(核心C); 4)实施分析计划(核心C,除了将由核心B执行的计算密集型协议); 5)广泛分发原始数据、统一的注释分析就绪文件,并分析结果,包括将适当的数据存入合格的访问数据库[国家老年痴呆症遗传学研究所存储站点(NIAGADS)和基因型和表型数据库(dbGaP)](核心B)。根据RFA AG 16001的要求,将与所有ADSP、RFA AG 16002和其他AD遗传学研究者合作,完善所有协调方案和分析计划。总体构成部分详细说明了拟由各核心执行的活动和分析。我们将使用单个和基于基因的分析来分析复制阶段数据。将分析单核苷酸变体(SNV)和结构变体(SV)。我们将对复制阶段和发现阶段数据进行综合分析。我们还将使用非ADSP数据执行扩展复制阶段。我们将分析来自通路网络分析、相互作用分析和多基因风险评分中所有阶段的数据。这些基因发现活动将为开发治疗药物带来潜在的靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GERARD DAVID SCHELLENBERG其他文献
GERARD DAVID SCHELLENBERG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GERARD DAVID SCHELLENBERG', 18)}}的其他基金
Coordinating Center for Genetics and Genomics of Alzheimer's Disease (CGAD)
阿尔茨海默病遗传学和基因组学协调中心 (CGAD)
- 批准号:
9892934 - 财政年份:2016
- 资助金额:
$ 25.76万 - 项目类别:
Project 1: Identifying genes and Pathways that impact Tau Toxicity in FTD
项目 1:识别影响 FTD 中 Tau 毒性的基因和途径
- 批准号:
10012956 - 财政年份:2016
- 资助金额:
$ 25.76万 - 项目类别:
Genome Center for Alzheimer's Disease (GCAD)
阿尔茨海默病基因组中心 (GCAD)
- 批准号:
10388085 - 财政年份:2016
- 资助金额:
$ 25.76万 - 项目类别:
Genome Center for Alzheimer's Disease (GCAD)
阿尔茨海默病基因组中心 (GCAD)
- 批准号:
10090891 - 财政年份:2016
- 资助金额:
$ 25.76万 - 项目类别:
Genome Center for Alzheimer's Disease (GCAD)
阿尔茨海默病基因组中心 (GCAD)
- 批准号:
10604370 - 财政年份:2016
- 资助金额:
$ 25.76万 - 项目类别:
3/3-Sequencing Autism Spectrum Disorder Extended Pedigrees
3/3 测序自闭症谱系障碍扩展谱系
- 批准号:
8659502 - 财政年份:2012
- 资助金额:
$ 25.76万 - 项目类别:
3/3-Sequencing Autism Spectrum Disorder Extended Pedigrees
3/3 测序自闭症谱系障碍扩展谱系
- 批准号:
8877310 - 财政年份:2012
- 资助金额:
$ 25.76万 - 项目类别:
相似海外基金
Broadening Participation Research: Understanding faculty attitudes, competency, and perceptions of providing career advising to African American STEM students at HBCUs
扩大参与研究:了解教师对 HBCU 的非裔美国 STEM 学生提供职业建议的态度、能力和看法
- 批准号:
2306671 - 财政年份:2023
- 资助金额:
$ 25.76万 - 项目类别:
Continuing Grant
Cognitive Behavioral Faith-based Depression Intervention For African American Adults (CB-FAITH): An Effectiveness And Implementation Trial
非裔美国成年人基于认知行为信仰的抑郁干预 (CB-FAITH):有效性和实施试验
- 批准号:
10714464 - 财政年份:2023
- 资助金额:
$ 25.76万 - 项目类别:
DELINEATING THE ROLE OF THE HOMOCYSTEINE-FOLATE-THYMIDYLATE SYNTHASE AXIS AND URACIL ACCUMULATION IN AFRICAN AMERICAN PROSTATE TUMORS
描述同型半胱氨酸-叶酸-胸苷酸合成酶轴和尿嘧啶积累在非裔美国人前列腺肿瘤中的作用
- 批准号:
10723833 - 财政年份:2023
- 资助金额:
$ 25.76万 - 项目类别:
Preventing Firearm Suicide Deaths Among Black/African American Adults
防止黑人/非裔美国成年人因枪支自杀死亡
- 批准号:
10811498 - 财政年份:2023
- 资助金额:
$ 25.76万 - 项目类别:
Exploring PTSD Symptoms, Barriers and Facilitators to Mindfulness-based Stress Reduction for Justice-Involved Black/African American Female Adolescents and Parents/Caregivers
探索创伤后应激障碍 (PTSD) 症状、障碍和促进因素,为涉及正义的黑人/非裔美国女性青少年和父母/照顾者进行基于正念的减压
- 批准号:
10593806 - 财政年份:2023
- 资助金额:
$ 25.76万 - 项目类别:
BCSER - PVEST: A Dynamic Framework for Investigating STEM Interest, Attitude and Identity Among African American Middle School Students
BCSER - PVEST:调查非裔美国中学生 STEM 兴趣、态度和身份的动态框架
- 批准号:
2327055 - 财政年份:2023
- 资助金额:
$ 25.76万 - 项目类别:
Standard Grant
Making the Connection: Understanding the dynamic social connections impacting type 2 diabetes management among Black/African American men
建立联系:了解影响黑人/非裔美国男性 2 型糖尿病管理的动态社会联系
- 批准号:
10782674 - 财政年份:2023
- 资助金额:
$ 25.76万 - 项目类别:
Building a Community-Based Mental Health Literacy Intervention for African American Young Adults
为非裔美国年轻人建立基于社区的心理健康素养干预措施
- 批准号:
10738855 - 财政年份:2023
- 资助金额:
$ 25.76万 - 项目类别:
African American Literature in "post" Post-Racial America
“后”后种族美国中的非裔美国文学
- 批准号:
23K00376 - 财政年份:2023
- 资助金额:
$ 25.76万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Impact of a Race-Based Stress Reduction Intervention on Well-Being, Inflammation, and DNA methylation in Older African American Women at Risk for Cardiometabolic Disease
基于种族的减压干预措施对有心血管代谢疾病风险的老年非洲裔美国女性的健康、炎症和 DNA 甲基化的影响
- 批准号:
10633624 - 财政年份:2023
- 资助金额:
$ 25.76万 - 项目类别: